Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

Abroad (travel likely)RecruitingPHASE2

Conditions

IgA Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Gabriel Montpied, Clermont-Ferrand, France
Contact: Study coordinator (Anne-Elisabeth HENG, MD) · aheng@chu-clermontferrand.fr · 0473751425
Hospices Civils de Lyon, Lyon, France
Contact: Study coordinator (Fitsum GUEBRE-EGZIABHER, MD) · fitsum.guebre-egziabher@chu-lyon.fr · 0472110260
AP-HM Hôpital de la Conception, Marseille, France
Contact: Study coordinator (Thomas ROBERT, MD) · thomas.robert@ap-hm.fr · 0662426166
APHP Hôpital Bichat, Paris, France
Contact: Study coordinator (Eric DAUGAS, PU-PH) · eric.daugas@aphp.fr · 0140257101
APHP Hôpital de Tenon, Paris, France
Contact: Study coordinator (Khalil EL KAROUI, PU-PH) · khalil.el-karoui@aphp.fr · 0156016317
CHU Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Sarah MEZAACHE, MD) · sarah.mezaache@chu-lyon.fr · 0478863712
CHU de Saint-Etienne, Saint-Etienne, France
Contact: Study coordinator (Nicolas MAILLARD, MD) · nicolas.maillard@chu-st-etienne.fr · 0477828127
Contact: Study coordinator (Carine LABRUYERE) · carine.labruyere@chu-st-etienne.fr · 0477120469

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of SHR-2173 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Shanghai, China

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

IgA Nephropathy (IgAN)

Abroad (travel likely)RecruitingPHASE3

Huangshan City, China · Wuhu, China

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

IgAN · C3G · Complement-mediated Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Doral, United States · Miami, United States

A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy

IgA Nephropathy (IgAN)

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China